Existing beta blocker investigated as novel sickle cell therapy

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.

Michigan stands out for its aggressive bird flu response. Will other states follow its lead?

For weeks now, as the H5N1 bird flu has been spreading into dairy cattle herds in more and more places, one state continues to lead

June 12, 2024

Why it’s so difficult to count the number of heat-related deaths

In late July, as parts of the southern U.S. approached 30 days of temperatures exceeding 100 degrees, President Biden took to the podium to announce

August 16, 2023

FDA approves Takeda’s colorectal cancer drug Fruzaqla – Pharmaceutical Technology

The drug is already approved in China and is also currently under review for marketing authorisation by the European Medicines Agency (EMA). Image credit: Shutterstock/Tada

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.